Company profile for Bajaj Healthcare

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd. have metamorphosed into specialty company and focused on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. B...
Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd. have metamorphosed into specialty company and focused on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. Bajaj healthcare Ltd. in its shot life span has gained loyalty from national and international customers and our products enjoy good fame in the overseas market.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
02 - 204 , Faiz-E-Qutbi, 375, Narshi Natha Street Mumbai - 400 009
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI South East Asia

Not Confirmed

envelop Contact Supplier

CPhI South East Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets
With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 1293

https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

Radio Compass
06 May 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel highlights Gentec Pharmaceutical's expertise in generic APIs, HPAPIs, and prostaglandins with more than 30 years of experience. Operating from EU-GMP-certified facilities, the company exports to over 70 countries worldwide.

Impressions: 99

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint
During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 

Impressions: 233

https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

#PharmaFlow by PHARMACOMPASS
10 Jul 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/news/bajaj-healthcare-receives-exclusive-rights-for-manufacturing-distribution-sales-of-finished-formulation-of-magnesium-l-threonate-16675

INDPHARMAPOST
17 Jan 2025

https://www.indiainfoline.com/article/news-top-story/bajaj-healthcare-moves-indian-patent-office-to-grant-compulsory-license-of-covid-19-drug-baricitinib-stock-hits-10-upper-circuit-121062900332_1.html

INDIAINFOLINE
29 Jun 2021

KDMF

read-more
read-more

01

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2025-02-13

Registration Number : 20230215-211-J-1444(1)

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post Gothada - 391 766, Tal-Savli, Dist. Vad...

blank

02

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Toru Corporation

Registration Date : 2023-02-15

Registration Number : 20230215-211-J-1444

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post Gothada - 391 766, Tal-Savli, Dist. Vad...

blank

03

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Bansen Co., Ltd.

Registration Date : 2022-11-22

Registration Number : 20210907-209-J-1100(A)

Manufacturer Name : Bajaj Healthcare Limited

Manufacturer Address : (Unit–II), Block No. 588, Savli- Karachia Road, At & Post: Gothada Tal: Savli, Dist...

blank

04

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Ace Biopharm Co., Ltd.

Registration Date : 2021-09-07

Registration Number : 20210907-209-J-1100

Manufacturer Name : Bajaj Healthcare Limited

Manufacturer Address : (Unit–II), Block No. 588, Savli- Karachia Road, At & Post: Gothada Tal: Savli, Dist...

blank

05

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : SG Biochem Co., Ltd.

Registration Date : 2025-02-28

Registration Number : 20250228-211-J-1731

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post Gothada-391 776, Tal. Savli, Dist. Vado...

blank

06

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : HiQ Farm Co., Ltd.

Registration Date : 2023-11-15

Registration Number : 20230313-211-J-1459(3)

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara, ...

blank

07

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Agerson Bio Co., Ltd.

Registration Date : 2023-03-13

Registration Number : 20230313-211-J-1459

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara, ...

blank

08

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Toru Corporation

Registration Date : 2023-07-28

Registration Number : 20230313-211-J-1459(2)

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara -...

blank

09

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2023-07-25

Registration Number : 20230313-211-J-1459(1)

Manufacturer Name : Bajaj Healthcare Limited (Unit...

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara -...

blank

10

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Bajaj Healthcare

Registrant Name : Bitifarm Co., Ltd.

Registration Date : 2020-12-24

Registration Number : 20201224-209-J-777

Manufacturer Name : Bajaj Healthcare Limited

Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post – Gothada, Tal-Savli, Dist – Vadoda...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Bajaj Healthcare Limited IN 400 009 Mumbai and get a quotation

Bajaj Healthcare Limited IN 400 009 Mumbai is a supplier offers 92 products (APIs, Excipients or Intermediates).

Find a price of Carbamazepine bulk with CEP offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Chlorhexidine Gluconate bulk with CEP offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Oxcarbazepine bulk with CEP offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Theobromine bulk with DMF offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of CAS 4826-71-5 bulk with DMF offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Metronidazole bulk with CEP offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Acefylline bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Ascorbic Acid bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Ascorbyl Palmitate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Calcium bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Carbamazepine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Chlorhexidine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Chlorhexidine Acetate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Chlorhexidine Gluconate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Chlorhexidine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Choline Dihydrogen Citrate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Choline Tartrate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Deferasirox bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Etofylline bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Fosfomycin Trometamol bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Inositol bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Octenidine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Oxtriphylline bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Piperazine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Theophylline Sodium Glycinate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Ticagrelor bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Vildagliptin bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Abaloparatide Acetate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Albendazole bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Alpha Lipoic Acid bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Amantadine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Apixaban bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Baricitinib bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Brexpiprazole bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Brivaracetam bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Butylated hydroxytoluene bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Caffeine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Caffeine Citrate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Calcium Ascorbate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Calcium Citrate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Calcium Dobesilate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of CAS 654671-77-9 bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Cenobamate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Cetirizine Dihydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Citicoline Sodium bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Diosmin bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Doxofylline bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Famciclovir bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Ferric Carboxymaltose bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Ferrous Bisglycinate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Fluoxetine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Fosfomycin Calcium bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Fosfomycin Sodium bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Glycine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Lacosamide bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Lafutidine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Leflunomide bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Lemborexant bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Leuprolide Acetate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Linaclotide bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Linagliptin bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Lumateperone Tosylate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Lysine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Magnesium Glycinate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Methionine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Metronidazole Benzoate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Mirogabalin Besylate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Noscapine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Octopamine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Octreotide Acetate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Papaverine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Pimavanserin Tartrate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Polyhexanide bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Ractopamine Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Rimegepant Sulfate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Rivaroxaban bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Sacubitril Sodium bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Sacubitril-Valsartan bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Semaglutide bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Sitagliptin Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Sitagliptin Phosphate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Sodium Ascorbate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Sodium saccharine bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Suvorexant bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Tirzepatide bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Trazodone Hydrochloride bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Upadacitinib bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Vibegron bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Zinc Ascorbate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Zinc Glycinate bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Undifferentiated linagliptin bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Find a price of Carboxymaltose ferric hydroxide complex salt bulk offered by Bajaj Healthcare Limited IN 400 009 Mumbai

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty